Hold Torrent Pharmaceuticals; target of Rs 2574: ICICI Securities

ICICI Securities recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 2574 in its research report dated May 27, 2020.
28-05-2020
Bigul

Torrent Pharma slips 6% on profit-booking; outlook remains a concern

Unlike peers, Torrent Pharma guided for a relatively moderate outlook across geographies, note analysts at Emkay Global Financial Services.
27-05-2020

Earnings Call Transcript - Q4FY20 for Torrent Pharmaceuticals

Conference Call with Torrent Pharma Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen to the full transcript.
26-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

The presentation on audited Financial Results for the quarter and year ended 31st March, 2020 to be made to analysts is enclosed for your records
26-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We hereby inform that the Company has scheduled a teleconference with Investors / Analysts on 26th May, 2020 at 05:30 P.M. to discuss the financial performance of the Company for the quarter and year ended 31st March, 2020.
20-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation For Board Meeting To Be Held On May 26, 2020

TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the year ended 31-Mar-20.
18-05-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Issue of Securities

Intimation regarding issue of Non-Convertible Debentures on Private Placement basis
14-05-2020
Next Page
Close

Let's Open Free Demat Account